Note 15 - Segment and Geographic Information (Tables)

3 Months Ended

Dec. 31, 2024

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

	Three Months Ended December 31,
	2024			2023
Revenue:
Sample Management Solutions	$	81,213		$	79,005
Multiomics		66,297			62,720
Total revenue	$	147,510		$	141,725
Adjusted operating income (loss):
Sample Management Solutions	$	2,317		$	(616	)
Multiomics		(2,503	)		(3,263	)
Segment adjusted operating loss		(186	)		(3,879	)
Amortization of completed technology		1,500			1,856
Amortization of intangible assets other than completed technology		4,573			5,371
Transformation costs (1)		3,046			41
Restructuring charges		431			786
Merger and acquisition costs and costs related to share repurchase (2)		1,570			4,321
Other unallocated corporate expenses		47			(9	)
Total operating loss		(11,353	)		(16,245	)
Interest income, net		4,298			9,955
Other income, net		1,203			518
Loss before income taxes	$	(5,852	)	$	(5,772	)

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

Assets:	December 31, 2024		September 30, 2024
Sample Management Solutions	$	840,580	$	859,353
Multiomics		454,958		462,825
Total assets	$	1,295,538	$	1,322,178

	December 31,		September 30,
	2024		2024
Segment assets	$	1,295,538	$	1,322,178
Cash and cash equivalents, restricted cash and marketable securities		501,277		490,707
Deferred tax assets		627		837
General corporate assets		12,591		23,631
Assets held for sale		231,177		262,688
Total assets	$	2,041,210	$	2,100,041

Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]

	Three Months Ended December 31,
	2024		2023
Geographic Location:
United States	$	93,469	$	90,127
China		14,888		14,898
United Kingdom		7,798		5,676
Rest of Europe		24,319		22,731
Asia Pacific/Other		7,036		8,293
Total revenue	$	147,510	$	141,725